支气管单向活瓣肺减容术的应用与创新  

Application and innovation of bronchoscopic lung volume reduction with endobronchial valve

作　　者：钟长镐[1] 游振锭 李时悦[1] Zhong Changhao;You Zhending;Li Shiyue(Department of Respiratory and Critical Care Medicine,The First Affiliated Hospital of Guangzhou Medical University,Guangzhou Institute of Respiratory Health,State Key Laboratory of Respiratory Disease,National Clinical Research Center for Respiratory Disease,Guangzhou 510145,China)

机构地区：[1]广州医科大学附属第一医院呼吸与危重症医学科,广州呼吸健康研究院,呼吸疾病国家重点实验室,广州510145

出　　处：《中华结核和呼吸杂志》2024年第11期1015-1018,共4页Chinese Journal of Tuberculosis and Respiratory Diseases

基　　金：国家重点研发项目(2022YFC2405204);广州市科技计划项目(202103010001)。

摘　　要：经支气管镜单向活瓣肺减容术(BLVR-EBV)通过在支气管镜下将单向活瓣置入于慢阻肺患者的肺气肿区域,使靶肺叶萎陷,改善患者呼吸功能,提高患者的生活质量及活动耐力。严格的选择标准与充分的术前评估是保障BLVR-EBV成功的关键,由于BLVR-EBV优异的术后表现,目前已被广泛应用于晚期慢阻肺患者的治疗中,甚至在部分特殊情况也有应用,如联合外科手术、治疗肺结核空洞等。本文将简述BLVR-EBV合适患者的选择、严格的围手术期管理、术后影响等方面的应用与创新。Bronchoscopic lung volume reduction with endobronchial valve(BLVR-EBV)involves the placement of an endobronchial valve(EBV)in the emphysema area of patients with chronic obstructive pulmonary disease(COPD)via bronchoscopy,resulting in the collapse of the target lung lobe.This procedure has been shown to improve pulmonary function,quality of life,and activity endurance in COPD patients.Strict selection criteria and thorough preoperative evaluation are essential to ensure the success of BLVR-EBV.Due to its excellent postoperative performance,BLVR-EBV has been widely used in the treatment of patients with end-stage COPD,including those with conditions such as pulmonary tuberculosis cavities or those requiring surgical treatment.This paper provided a brief overview of the application and innovation of BLVR-EBV in patient assessment,perioperative management,and postoperative outcomes.

关 键 词：单向活瓣 肺结核空洞 围手术期管理 肺减容术 慢阻肺患者 支气管镜 术前评估 应用与创新 

分 类 号：R563.9[医药卫生—呼吸系统]